By 1 month, there is increased collagen deposition around the implant and evidence of de novo production of Type I collagen, supported by studies confirming enhanced staining of Type I procollagen, a soluble precursor to collagen, as well as upregulation of gene expression for Types I and III procollagen and profibrotic growth factors in Restylane-treated areas.13